1. Entry
     Planned Intervention Act (V2) (2.16.840.1.113883.10.20.22.4.146)
    1. notype
       Author Participation (2.16.840.1.113883.10.20.22.4.119)
    2. Entry
       Advance Directive Observation (V3) (2.16.840.1.113883.10.20.22.4.48)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. datatypelevel
         US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
      3. datatypelevel
         US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
      4. datatypelevel
         US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
    3. Entry
       Immunization Activity (V3) (2.16.840.1.113883.10.20.22.4.52)
      1. Entry
         Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
      2. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      6. Entry
         Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      7. Entry
         Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        3. datatypelevel
           US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
        4. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      8. Entry
         Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        1. Entry
           Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          3. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          6. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          7. @
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        2. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. @
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        3. Entry
           Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      9. Entry
         Immunization Refusal Reason (2.16.840.1.113883.10.20.22.4.53)
      10. Entry
         Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
      11. Entry
         Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    4. Entry
       Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
      1. Entry
         Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
      2. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      6. Entry
         Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      7. Entry
         Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        3. datatypelevel
           US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
        4. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      8. Entry
         Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        1. Entry
           Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          3. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          6. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          7. @
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        2. @
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        3. Entry
           Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      9. Entry
         Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
        1. datatypelevel
           US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
      10. Entry
         Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
      11. Entry
         Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
      12. Entry
         Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    5. Entry
       Procedure Activity Act (V2) (2.16.840.1.113883.10.20.22.4.12)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
      3. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    6. Entry
       Intervention Act (V2) (2.16.840.1.113883.10.20.22.4.131)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Advance Directive Observation (V3) (2.16.840.1.113883.10.20.22.4.48)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. datatypelevel
           US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
        3. datatypelevel
           US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        4. datatypelevel
           US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
      3. Entry
         Immunization Activity (V3) (2.16.840.1.113883.10.20.22.4.52)
        1. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Immunization Refusal Reason (2.16.840.1.113883.10.20.22.4.53)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      4. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      5. Entry
         Procedure Activity Act (V2) (2.16.840.1.113883.10.20.22.4.12)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      6. @
         Intervention Act (V2) (2.16.840.1.113883.10.20.22.4.131)
      7. Entry
         Procedure Activity Observation (V2) (2.16.840.1.113883.10.20.22.4.13)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        6. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      8. Entry
         Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        3. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        6. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. @
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        7. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. @
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          2. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
      9. Entry
         Encounter Activity (V3) (2.16.840.1.113883.10.20.22.4.49)
        1. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        2. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        3. Entry
           Encounter Diagnosis (V3) (2.16.840.1.113883.10.20.22.4.80)
          1. Entry
             Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Age Observation (2.16.840.1.113883.10.20.22.4.31)
            3. Entry
               Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
            4. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            5. Entry
               Problem Status (2.16.840.1.113883.10.20.22.4.6)
      10. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      11. Entry
         Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
        1. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        2. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      12. Entry
         Nutrition Recommendation (2.16.840.1.113883.10.20.22.4.130)
        1. Entry
           Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        2. Entry
           Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        3. Entry
           Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        5. Entry
           Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          5. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          6. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          7. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        6. Entry
           Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      13. Entry
         Entry Reference (2.16.840.1.113883.10.20.22.4.122)
      14. Entry
         Entry Reference (2.16.840.1.113883.10.20.22.4.122)
      15. Entry
         Handoff Communication Participants (2.16.840.1.113883.10.20.22.4.141)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      16. Entry
         Planned Intervention Act (V2) (2.16.840.1.113883.10.20.22.4.146)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Advance Directive Observation (V3) (2.16.840.1.113883.10.20.22.4.48)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          3. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          4. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
        3. Entry
           Immunization Activity (V3) (2.16.840.1.113883.10.20.22.4.52)
          1. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. Entry
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. notype
                   Author Participation (2.16.840.1.113883.10.20.22.4.119)
                3. Entry
                   Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
                4. Entry
                   Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
                5. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                6. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                7. Entry
                   Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. datatypelevel
                     US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                  4. Entry
                     Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                    1. Entry
                       Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                    2. Entry
                       Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                    3. Entry
                       Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                8. @
                   Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
                9. Entry
                   Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                  1. datatypelevel
                     US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
                10. Entry
                   Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
                11. Entry
                   Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
                12. Entry
                   Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Immunization Refusal Reason (2.16.840.1.113883.10.20.22.4.53)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        4. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        5. Entry
           Procedure Activity Act (V2) (2.16.840.1.113883.10.20.22.4.12)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. Entry
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              1. Entry
                 Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
                1. notype
                   Author Participation (2.16.840.1.113883.10.20.22.4.119)
                2. Entry
                   Product Instance (2.16.840.1.113883.10.20.22.4.37)
                3. Entry
                   Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
                4. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                5. Entry
                   Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
                6. @
                   Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
                7. @
                   Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              2. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              3. Entry
                 Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        6. @
           Intervention Act (V2) (2.16.840.1.113883.10.20.22.4.131)
        7. Entry
           Procedure Activity Observation (V2) (2.16.840.1.113883.10.20.22.4.13)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. Entry
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              1. Entry
                 Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
                1. notype
                   Author Participation (2.16.840.1.113883.10.20.22.4.119)
                2. Entry
                   Product Instance (2.16.840.1.113883.10.20.22.4.37)
                3. Entry
                   Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
                4. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                5. Entry
                   Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
                6. @
                   Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
                7. @
                   Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              2. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              3. Entry
                 Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          6. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. Entry
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Product Instance (2.16.840.1.113883.10.20.22.4.37)
              3. Entry
                 Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
              4. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              5. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              6. Entry
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. notype
                   Author Participation (2.16.840.1.113883.10.20.22.4.119)
                3. Entry
                   Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
                4. Entry
                   Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
                5. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                6. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                7. Entry
                   Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. datatypelevel
                     US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                  4. Entry
                     Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                    1. Entry
                       Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                    2. Entry
                       Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                    3. Entry
                       Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
                8. @
                   Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
                9. Entry
                   Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                  1. datatypelevel
                     US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
                10. Entry
                   Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
                11. Entry
                   Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
                12. Entry
                   Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
              7. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            2. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        8. Entry
           Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          3. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          6. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. Entry
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              1. @
                 Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
              2. @
                 Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              3. Entry
                 Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          7. Entry
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            1. @
               Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            2. Entry
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              3. Entry
                 Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
              4. Entry
                 Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
              5. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              6. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              7. Entry
                 Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. datatypelevel
                   US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
                4. Entry
                   Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                  1. Entry
                     Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                  2. Entry
                     Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                  3. Entry
                     Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
              8. @
                 Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
              9. Entry
                 Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
                1. datatypelevel
                   US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
              10. Entry
                 Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
              11. Entry
                 Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
              12. Entry
                 Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
            3. Entry
               Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Encounter Activity (V3) (2.16.840.1.113883.10.20.22.4.49)
          1. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          2. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          3. Entry
             Encounter Diagnosis (V3) (2.16.840.1.113883.10.20.22.4.80)
            1. Entry
               Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
              2. Entry
                 Age Observation (2.16.840.1.113883.10.20.22.4.31)
              3. Entry
                 Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
              4. Entry
                 Priority Preference (2.16.840.1.113883.10.20.22.4.143)
                1. notype
                   Author Participation (2.16.840.1.113883.10.20.22.4.119)
              5. Entry
                 Problem Status (2.16.840.1.113883.10.20.22.4.6)
        10. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        11. Entry
           Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
          1. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          2. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        12. Entry
           Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        13. Entry
           Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        14. Entry
           Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        15. Entry
           Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        16. Entry
           Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        17. Entry
           Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          5. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          6. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          7. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. Entry
             Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
        18. Entry
           Nutrition Recommendation (2.16.840.1.113883.10.20.22.4.130)
          1. Entry
             Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            3. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          2. Entry
             Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          3. Entry
             Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
          5. Entry
             Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            4. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            5. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            6. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            7. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. Entry
               Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
          6. Entry
             Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Priority Preference (2.16.840.1.113883.10.20.22.4.143)
              1. notype
                 Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        19. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        20. Entry
           Entry Reference (2.16.840.1.113883.10.20.22.4.122)
        21. Entry
           Handoff Communication Participants (2.16.840.1.113883.10.20.22.4.141)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        22. Entry
           Planned Immunization Activity (2.16.840.1.113883.10.20.22.4.120)
          1. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        23. Entry
           External Document Reference (2.16.840.1.113883.10.20.22.4.115)
      17. Entry
         External Document Reference (2.16.840.1.113883.10.20.22.4.115)
    7. Entry
       Procedure Activity Observation (V2) (2.16.840.1.113883.10.20.22.4.13)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
      3. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. Entry
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            2. Entry
               Product Instance (2.16.840.1.113883.10.20.22.4.37)
            3. Entry
               Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
            4. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            5. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            6. @
               Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            7. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      6. Entry
         Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        1. Entry
           Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Product Instance (2.16.840.1.113883.10.20.22.4.37)
          3. Entry
             Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
          4. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          5. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          6. Entry
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
            3. Entry
               Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
            4. Entry
               Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
            5. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            6. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            7. Entry
               Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. datatypelevel
                 US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
              4. Entry
                 Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
                1. Entry
                   Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
                2. Entry
                   Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
                3. Entry
                   Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
            8. @
               Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
            9. Entry
               Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
              1. datatypelevel
                 US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
            10. Entry
               Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
            11. Entry
               Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
            12. Entry
               Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
          7. @
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        2. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. @
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        3. Entry
           Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
    8. Entry
       Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Product Instance (2.16.840.1.113883.10.20.22.4.37)
      3. Entry
         Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
      4. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      5. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      6. Entry
         Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        7. Entry
           Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. Entry
             Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
          3. datatypelevel
             US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
          4. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          1. @
             Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
          2. @
             Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          3. Entry
             Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
        9. Entry
           Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
          1. datatypelevel
             US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
        10. Entry
           Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
        11. Entry
           Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
        12. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      7. Entry
         Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
        1. @
           Procedure Activity Procedure (V2) (2.16.840.1.113883.10.20.22.4.14)
        2. Entry
           Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.16)
          1. Entry
             Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
          2. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          3. Entry
             Drug Vehicle (2.16.840.1.113883.10.20.22.4.24)
          4. Entry
             Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
          5. Entry
             Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          6. Entry
             Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. Entry
               Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          7. Entry
             Medication Dispense (V2) (2.16.840.1.113883.10.20.22.4.18)
            1. Entry
               Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
            2. Entry
               Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
            3. datatypelevel
               US Realm Address (AD.US.FIELDED) (2.16.840.1.113883.10.20.22.5.2)
            4. Entry
               Medication Supply Order (V2) (2.16.840.1.113883.10.20.22.4.17)
              1. Entry
                 Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
              2. Entry
                 Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
              3. Entry
                 Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
          8. @
             Reaction Observation (V2) (2.16.840.1.113883.10.20.22.4.9)
          9. Entry
             Drug Monitoring Act (2.16.840.1.113883.10.20.22.4.123)
            1. datatypelevel
               US Realm Person Name (PN.US.FIELDED) (2.16.840.1.113883.10.20.22.5.1.1)
          10. Entry
             Substance Administered Act (2.16.840.1.113883.10.20.22.4.118)
          11. Entry
             Medication Free Text Sig (2.16.840.1.113883.10.20.22.4.147)
          12. Entry
             Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
        3. Entry
           Severity Observation (V2) (2.16.840.1.113883.10.20.22.4.8)
    9. Entry
       Encounter Activity (V3) (2.16.840.1.113883.10.20.22.4.49)
      1. Entry
         Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
      2. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      3. Entry
         Encounter Diagnosis (V3) (2.16.840.1.113883.10.20.22.4.80)
        1. Entry
           Problem Observation (V3) (2.16.840.1.113883.10.20.22.4.4)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
          2. Entry
             Age Observation (2.16.840.1.113883.10.20.22.4.31)
          3. Entry
             Prognosis Observation (2.16.840.1.113883.10.20.22.4.113)
          4. Entry
             Priority Preference (2.16.840.1.113883.10.20.22.4.143)
            1. notype
               Author Participation (2.16.840.1.113883.10.20.22.4.119)
          5. Entry
             Problem Status (2.16.840.1.113883.10.20.22.4.6)
    10. Entry
       Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
    11. Entry
       Non-Medicinal Supply Activity (V2) (2.16.840.1.113883.10.20.22.4.50)
      1. Entry
         Product Instance (2.16.840.1.113883.10.20.22.4.37)
      2. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
    12. Entry
       Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      4. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
    13. Entry
       Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
      3. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
    14. Entry
       Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      4. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      5. Entry
         Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
    15. Entry
       Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      2. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      4. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      5. Entry
         Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
    16. Entry
       Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
      1. Entry
         Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
      2. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      6. Entry
         Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    17. Entry
       Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
      1. Entry
         Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
      2. Entry
         Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
      3. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Product Instance (2.16.840.1.113883.10.20.22.4.37)
      5. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      6. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      7. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      8. Entry
         Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
    18. Entry
       Nutrition Recommendation (2.16.840.1.113883.10.20.22.4.130)
      1. Entry
         Planned Encounter (V2) (2.16.840.1.113883.10.20.22.4.40)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Service Delivery Location (2.16.840.1.113883.10.20.22.4.32)
        3. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      2. Entry
         Planned Medication Activity (V2) (2.16.840.1.113883.10.20.22.4.42)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        5. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        6. Entry
           Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
      3. Entry
         Planned Observation (V2) (2.16.840.1.113883.10.20.22.4.44)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Planned Procedure (V2) (2.16.840.1.113883.10.20.22.4.41)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        5. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      5. Entry
         Planned Supply (V2) (2.16.840.1.113883.10.20.22.4.43)
        1. Entry
           Medication Information (V2) (2.16.840.1.113883.10.20.22.4.23)
        2. Entry
           Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
        3. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        4. Entry
           Product Instance (2.16.840.1.113883.10.20.22.4.37)
        5. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        6. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        7. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
        8. Entry
           Planned Coverage (2.16.840.1.113883.10.20.22.4.129)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
      6. Entry
         Planned Act (V2) (2.16.840.1.113883.10.20.22.4.39)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
        2. Entry
           Priority Preference (2.16.840.1.113883.10.20.22.4.143)
          1. notype
             Author Participation (2.16.840.1.113883.10.20.22.4.119)
        3. Entry
           Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
        4. Entry
           Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
    19. Entry
       Entry Reference (2.16.840.1.113883.10.20.22.4.122)
    20. Entry
       Entry Reference (2.16.840.1.113883.10.20.22.4.122)
    21. Entry
       Handoff Communication Participants (2.16.840.1.113883.10.20.22.4.141)
      1. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
    22. Entry
       Planned Immunization Activity (2.16.840.1.113883.10.20.22.4.120)
      1. Entry
         Immunization Medication Information (V2) (2.16.840.1.113883.10.20.22.4.54)
      2. notype
         Author Participation (2.16.840.1.113883.10.20.22.4.119)
      3. Entry
         Priority Preference (2.16.840.1.113883.10.20.22.4.143)
        1. notype
           Author Participation (2.16.840.1.113883.10.20.22.4.119)
      4. Entry
         Indication (V2) (2.16.840.1.113883.10.20.22.4.19)
      5. Entry
         Instruction (V2) (2.16.840.1.113883.10.20.22.4.20)
      6. Entry
         Precondition for Substance Administration (V2) (2.16.840.1.113883.10.20.22.4.25)
    23. Entry
       External Document Reference (2.16.840.1.113883.10.20.22.4.115)